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ABSTRACT
In patients with rectal prolapse is the prevalence of colorectal cancer increased, 
suggesting that a colorectal tumor may induce rectal prolapse. Establishment of tumor 
xenografts in immunodeficient mice after orthotopic inoculations of human colorectal 
cancer cells into the caecal wall is a widely used approach for the study of human 
colorectal cancer progression and preclinical evaluation of therapeutics. Remarkably, 
70% of young mice carrying a COLO320DM caecal tumor showed symptoms of 
intussusception of the large bowel associated with intestinal lumen obstruction and 
rectal prolapse. The quantity of the COLO320DM bioluminescent signal of the first 
three weeks post-inoculation predicts prolapse in young mice. Rectal prolapse was not 
observed in adult mice carrying a COLO320DM caecal tumor or young mice carrying 
a HT29 caecal tumor. In contrast to HT29 tumors, which showed local invasion and 
metastasis, COLO320DM tumors demonstrated a non-invasive tumor with pushing 
borders without presence of metastasis. In conclusion, rectal prolapse can be linked 
to a non-invasive, space-occupying COLO320DM tumor in the gastrointestinal tract 
of young immunodeficient mice. These data reveal a model that can clarify the 
association of patients showing rectal prolapse with colorectal cancer.
INTRODUCTION
Rectal prolapse is the complete protrusion of the 
rectum through the anal canal. In children, rectal prolapse 
is related to chronic constipation, acute diarrheal disease, 
cystic fibrosis, and neurologic/anatomic abnormalities [1]. 
In adults, rectal prolapse is associated with pregnancy, 
obesity, perineal injury, chronic constipation, or other 
disorders leading to enhanced intra-abdominal pressure [2]. 
Interestingly, rectal prolapse can also occur as a symptom 
of colorectal cancer (CRC). Patients with rectal prolapse 
are reported to have a 4.2-fold relative risk for CRC in 
comparison with a control group [3]. This may indicate that 
rectal prolapse is induced by CRC. Here, we demonstrate a 
murine model that resembles the situation of these patients.
To study CRC in vivo, several murine models are 
available [4]. Genetically engineered mouse models are 
induced by overexpression or knockdown of a given 
dominant oncogene/tumor suppressor gene, respectively. 
Of note, this approach is not representative of the natural 
history of the neoplasia since malignant human tumors are 
considered to be induced by the sequential combination 
and progressive accumulation of 6-9 genetic defects. 
Multiplexed genome engineering by transfection-based 
CRISPR/Cas9 delivery may offer novel opportunities to 
study the complexity of cancer [5].
Oncotarget2www.impactjournals.com/oncotarget
Direct orthotopic implantation of human CRC cells 
in their natural microenvironment is actually considered as 
a pertinent approach for modeling CRC progression. High 
tumor take rates and spontaneous metastases at clinically 
relevant rates were observed when HT29, a human CRC 
cell line, was injected orthotopically into the caecal wall 
of immunodeficient mice [6]. Furthermore, the orthotopic 
model is shown to be a relevant model for therapy studies 
[6–8]. Intra-caecal inoculation of several cell lines such 
as HCT-116, SW-620, DLD-1 (HCT8/E11), HT29, KM12 
has been reported [6–13].
COLO320DM cells differ from other reported 
epithelial cell lines such as HCT8/E11, HT29, SW-480 
and HCT-116. Most of the CRC cell lines adhere strongly 
to the culture flask and form dense cell colonies. They 
have cell membranes with interdigitating brush borders 
and secrete variable amounts of carcinoembryonic antigen. 
COLO320DM does not form dense cell colonies and the 
cells easily detach from the culture flask. The cells are 
round with few microvilli or desmosomes. COLO320DM 
is reported to secrete serotonin and catecholamines such 
as norepinephrine and epinephrine and are referred to as 
amine precursor uptake and decarboxylation (APUD) cells 
[14]. Moreover, COLO320DM contains double minutes, 
defined as extrachromosomal DNA [14]. Intra-caecal 
injection of single cell suspensions of COLO320DM was 
not yet described.
Because the multifactorial interactions between 
cancer cells and the tumor stroma determine growth, 
angiogenesis and metastasis to distal organs, the orthotopic 
model is the most realistic replication of CRC [6, 15]. The 
tumor stroma consists of ostensibly normal cells such 
as immune cells, endothelial cells and cancer-associated 
fibroblasts (CAFs) as principal components. We have 
previously shown that colorectal CAFs contribute to most 
of the cancer hallmarks, promoting CRC progression and 
metastasis [16].
In the present study, young mice, in contrast to 
adult mice, were susceptible to rectal prolapse when a 
growing caecal tumor of COLO320DM cells was present. 
However, rectal prolapse was not observed in adult mice 
carrying a COLO320DM caecal tumor or young mice 
carrying a HT29 caecal tumor. To our knowledge, we are 
the first to describe an association between orthotopic 
intra-caecal xenografts of CRC cells and rectal prolapse 
in mice.
RESULTS
COLO320DM characterization and 
subcutaneous (SC) implantation
In vitro cultures of COLO320DM showed mainly 
a round morphotype (Figure 1A). Neuroendocrine 
origin of the cell line was suggested by Quinn et al. [14] 
but neuroendocrine markers CD56, chromogranin and 
synaptophysin were negative in COLO320DM tumors 
(Figure 2A). For a neuroendocrine tumor two out of 
three markers should be positive. Lack of expression of 
cytokeratin, an intermediate filament protein present in the 
intracytoplasmic cytoskeleton of epithelial cells, confirmed 
a non-epithelial phenotype. Furthermore vimentin, an 
intermediate filament expressed in mesenchymal cells, 
was detected in COLO320DM. Membrane receptor β1-
integrin and type-1 transmembrane proteins N-cadherin, 
E-cadherin and P-cadherin, which are important for 
cell-cell and cell-matrix adhesion, were not expressed in 
COLO320DM. Accordingly, this cell line had no tight 
cell-cell contacts despite the expression of β-catenin, 
which needs cadherins to form an association with the 
actin filaments (Figure 2B). In contrast to epithelial 
HCT8/E11 cells, COLO320DM cells did not show 
serum-induced chemotactic migration as demonstrated 
by real-time monitoring of cell migration (Figure 2C). 
Type I collagen invasion assay revealed a non-invasive 
morphotype of COLO320DM cells, while in HCT8/E11 
cells some invasive extensions were observed (Figure 
2D). Previously, two studies showed tumor development 
following SC inoculation of COLO320DM in BALB/c nu/
nu mice [17, 18]. In a first experiment Swiss nu/nu mice 
were SC injected with COLO320DM either alone or in 
combination with CAFs (Figure 1B). Tumor growth was 
monitored by bioluminescence imaging (Figure 2E, 2F). 
One day after SC injection, all mice (n=15) demonstrated 
a luciferase positive signal at the site of injection. This 
indicates that the procedure was well performed and 
cancer cells were present initially. However, one week 
later the signal had disappeared and remained absent up to 
6 weeks post-inoculation (Figure 2E, 2F). In accordance, 
no macroscopic tumor was detectable. Histological 
assessment confirmed that COLO320DM cells injected at 
the SC, ectopic site did not develop tumors. Results were 
similar for mice injected with COLO320DM alone or in 
combination with CAFs (Figure 2F).
Orthothopic implantation of COLO320DM or 
HT29
To resemble a more natural environment for CRC, 
an orthotopic model was developed by intra-caecal 
injection of CRC cells in combination with CAFs. Under 
2.5x magnification and using a 30G needle, cells were 
injected in the caecal wall. Initially, the injection technique 
was established using methylene blue injections. When 
injected too deeply, the dye was diluted by the bowel 
content. A too superficial injection resulted in peritoneal 
leakage (data not shown). Bleb-formation after injection 
served as a quality control for the technique (Figure 1C). 
Orthotopic injection turned out to be a safe procedure 
as no animals showed morbidity or mortality because 
of the surgery. This procedure was performed with 
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COLO320DM in adult and young mice and with HT29 
cells in young mice. CRC cells were combined with 
CAFs in every experiment. In contrast to SC injection, 
orthotopically injected mice were able to develop a tumor. 
In all groups a tumor take rate of 62.5% was observed, 
suggesting the reproducibility of the technique.
Orthotopic injection of COLO320DM: tumor 
growth and survival of adult versus young mice
Weekly bioluminescence imaging was used to 
follow up mice orthotopically injected with COLO320DM 
and CAFs. Results for four representative adult and 
young mice are displayed in Figure 3A. A local tumor 
was observed in five out of eight (62.5%) adult mice 
and in ten out of sixteen (62.5%) young mice (Table 1). 
Quantification of bioluminescence revealed no significant 
changes in adult compared to young mice (Figure 3B). 
However, young mice with a caecum tumor showed a 
significant lower survival than adult mice with a caecum 
tumor (p=0.020) (Figure 3C). Seven out of ten (70%) 
young mice with a caecum tumor showed rectal prolapse 
and had to be sacrificed at the latest six weeks after 
Figure 1: Overview of the performed in vivo experiments. A. Phase/contrast pictures of human CRC cell lines COLO320DM and 
HT29. B. Picture of SC inoculation of COLO320DM. C. In the orthotopic model, the caecum was gently exteriorized and flattened with a 
forceps before injecting the cells into the caecal wall. A small bleb was a sign of successful injection. SC = subcutaneous.
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Figure 2: COLO320DM characterization and SC implantation. A. Immunohistochemistry for neuroendocrine markers CD56, 
chromogranin and synaptophysin in COLO320DM tumors. Normal pancreas was used as positive control. B. Western blot for different 
EMT markers in COLO320DM and luciferase transfected COLO320DM cells compared to HCT8/E11 and CAFs. C. Real-time monitoring 
of CRC cell migration by measuring electrical impedance during 24h. The cell index is displayed as mean ± SD. D. Phase/contrast image 
of COLO320DM and HCT8/E11 cells on type I collagen gels. The arrow indicates an invasive extension. E. In vivo bioluminescence 
monitoring of young mice subcutaneously inoculated with COLO320DM cells in combination with CAFs. Four representative mice are 
shown. F. Bioluminescence quantification of young mice subcutaneously inoculated, presented as the mean bioluminescence ± SD of mice 
inoculated with COLO320DM alone or in combination with CAFs.
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inoculation (Figure 4B). In contrast, no rectal prolapse 
occurred in adult mice (Table 1). Consequently, young 
mice had a significantly higher chance to develop rectal 
prolapse (p=0.026). Rectal prolapse was not observed in 
young mice that did not grow a local tumor after intra-
caecal injection with COLO320DM (p=0.011). In the first 
three weeks after inoculation of the cells, a correlation 
is observed between the intensity of the bioluminescent 
signal and the occurrence of prolapse in the six weeks 
following the inoculation (p=0.005). Young mice with a 
higher bioluminescent signal two and three weeks post-
inoculation had a higher chance to develop rectal prolapse 
(p=0.030 and 0.020 respectively, Figure 3D).
Necropsy and histopathology of mice exhibiting 
rectal prolapse
When an animal started to exhibit symptoms of 
morbidity it was sacrificed and necropsied followed by 
histological examination. Young mice orthotopically 
injected with COLO320DM exhibiting rectal prolapse 
were characterized by a protrusion of the rectum 
beyond the anus. Necropsy of these mice demonstrated 
intussusception of the caecum, meaning that the caecum 
invaginated the large bowel. This intussusception resulted 
in bowel obstruction (Figure 4B). Hematoxylin and eosin 
(H&E) staining of primary COLO320DM tumors showed 
Figure 3: Adult versus young mice orthotopically injected with COLO320DM. A. In vivo bioluminescence monitoring. Four 
representative adult or young mice are shown. B. Quantification of bioluminescence. Only mice carrying a COLO320DM caecum tumor 
are included. C. Survival curve of mice carrying a COLO320DM caecum tumor. D. Bioluminescence quantification of young mice with a 
COLO320DM caecal tumor the first three weeks after inoculation.
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Table 1: Local tumor growth and appearance of rectal prolapse in young or adult mice SC or orthotopically injected 
with human CRC cell lines
Location of 
injection Cell line Age Mice (n)
Local tumor take 
rate (%)
Rectal prolapse 
(%)
SC COLO320DM 6 weeks 15 0/15 (0 %) -
Intra-caecal COLO320DM 6 weeks 16 10/16 (62.5 %) 7/10 (70 %)
Intra-caecal COLO320DM > 12 weeks 8 5/8 (62.5 %) 0/5 (0 %)
Intra-caecal HT29 6 weeks 8 5/8 (62.5 %) 0/5 (0 %)
SC = subcutaneous.
Figure 4: Orthotopic COLO320DM versus HT29 tumors in young mice. A. H&E staining of the local COLO320DM tumor 
showing pushing borders. B. Rectal prolapse, obstruction of the large bowel and intussusception of the caecum was observed in mice 
carrying a COLO320DM tumor. C. H&E staining of the primary HT29 tumor demonstrating infiltration in the normal adjacent host tissue. 
D. No rectal prolapse, obstruction of the large bowel or intussusception of the caecum was observed using HT29 cells. E. H&E staining of 
HT29 cancer cell spread to mesenterium, diaphragm and lung. NM = normal mucosa, CC = cancer cells, S = submucosa, MP = muscularis 
propria.
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a non-invasive tumor with pushing borders. The tumor 
was located in the submucosa (Figure 4A). Also other 
organs were prelevated, but H&E stainings could not 
reveal metastases confirming the local intra-abdominal 
bioluminescent signal.
Orthotopic injection in young mice: HT29 versus 
COLO320DM
HT29 has a more epithelial morphotype with 
tight cell-cell contacts and is more differentiated than 
COLO320DM (Figure 1A). Five out of eight (62.5%) 
young mice orthotopically injected with HT29 and 
CAFs developed a local tumor. In contrast to young 
mice orthotopically injected with COLO320DM, no 
rectal prolapses were observed (p=0.026)(Table 1). 
The caecum implanted with HT29 and CAFs did not 
invaginate the large bowel and no obstruction was seen 
in the first six weeks after inoculation. H&E staining of 
the primary tumor showed differentiated cancer cell nests 
that invaded into the normal adjacent host tissue. HT29 
gave rise to spread of cancer cells to several sites such 
as mesenterium, liver, diaphragm and lungs (Figure 4E). 
This systemic spread did not cause death in the first six 
weeks post-inoculation. Survival of young mice with a 
local HT29 tumor was therefore significantly better than 
for young mice with a COLO320DM tumor (p=0.020; 
Supplementary Figure S1).
DISCUSSION
The orthotopic model yields a tumor take rate of 
62.5% in all groups, independent of the cell line used or 
the age of the mice. In literature tumor take rates from 
> 50% up to 100% are described for different epithelial 
cell lines, such as HCT-116, SW-620, DLD-1 or HCT-8/
E11 and HT29 (Table 2). Although these cell lines were 
also intra-caecally injected in immunodeficient mice 
aged from 4 weeks until 12 weeks, no rectal prolapse 
was reported (Table 2) [6–13]. This is in line with our 
findings that rectal prolapse only occurred in young mice 
bearing a COLO320DM caecum tumor and not in young 
mice with an epithelial HT29 caecum tumor in the same 
mouse strain from the same age (Table 2). Consequently, 
we hypothesize that the development of rectal prolapse is 
due to a space-occupying, non-invasive tumor or through 
the intrinsic characteristics of the COLO320DM cell 
line either through secretion of serotonin or through its 
unique response to a young environment. The presence 
of a caecum tumor was provocative to rectal prolapse, 
excluding that the technical procedure was the cause.
COLO320DM cells are referred to as APUD 
cells secreting serotonin and catecholamines such as 
norepinephrine and epinephrine [14], but they do not 
express the neuroendocrine markers CD56, chromogranin 
or synaptophysin. In comparison with epithelial 
HCT8/E11, COLO320DM cells exhibit epithelial to 
mesenchymal transition (EMT) features demonstrated 
by the lack of epithelial markers E-cadherin, EpCAM, 
cytokeratin and the expression of mesenchymal marker 
vimentin [19, 20]. Nevertheless, the presence of these 
EMT markers does not correspond with a pro-migratory/
invasive phenotype in vitro nor in vivo.
Serotonin (5-hydroxytryptamine, 5-HT) regulates 
the colonic transit by modulating intestinal motility, 
sensitivity, inflammation and secretion [21–23]. Mast cells 
are also a source of serotonin and the number of mast cells 
is increased in adults with irritable bowel syndrome (IBS) 
[22]. Similar results were obtained by Cremon et al. who 
demonstrated a 10-fold higher serotonin release in patients 
with IBS [24]. In accordance, children with IBS showed a 
higher serotonin content in the rectal mucosa [25]. These 
examples prove that changes in serotonin availability can 
disturb the balance in the gastrointestinal tract. Serotonin 
can influence the immune system and serotonin synthesis 
is increased in Crohn’s disease [26]. Also in experimental 
models of colitis the serotonin content was increased [27, 
28]. Treating serotonin-lacking mice with 5-HTP, the 
direct precursor of serotonin, increased the severity of 
colitis demonstrating a pivotal mediating role of serotonin 
in intestinal inflammation [29, 30]. Rectal prolapse 
frequently occurred in mice with rectal inflammatory 
bowel disease [31]. Consequently, serotonin may play a 
role in the development of rectal prolapse. However, Dolk 
et al. immunocytochemically investigated the occurrence 
and distribution of endocrine cells secreting serotonin on 
patients with rectal prolapse and on normal rectal mucosa 
and did not detect significant differences [32].
Rectal prolapse, which is also known as procidentia, 
is defined as a protrusion of all layers of the rectal wall 
through the anal canal [33–36]. This corresponds to 
complete or full-thickness rectal prolapse. If the rectal 
wall prolapses but does not protrude through the anus, it 
is termed an occult (internal) rectal prolapse or a rectal 
intussusception [36–38]. The prevalence of rectal prolapse 
in patients is low and occurs at the extremes of age [35, 
36, 39]. In children it is usually diagnosed by the age of 3 
years [36, 39]. This is in accordance to our results which 
demonstrated rectal prolapse in young mice. In adults, 
rectal prolapse mainly occurs in patients over 50 years 
old and women are more affected, representing 80% to 
90% of the patients [35, 36, 39]. Elderly females are more 
susceptible because of the damaging effect of pregnancy 
and menopause on the pelvic floor [40]. Since the mice 
exhibiting prolapse were young and nulliparous, this 
cannot be a cause in our experiments. In children, rectal 
prolapse may result from the lack of the natural sacral 
curve. Because there is little or no anorectal angulation 
any increase in intra-abdominal pressure can lead to an 
increase in anorectal pressure, causing rectal prolapse [41].
In contrast to humans, rectal prolapse occurs 
regularly in laboratory mice. The higher incidence in mice 
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may be explained by the short and poorly supported distal 
colon of mice, which lacks a serosal covering [42, 43].
A space-occupying tumor within the gastrointestinal 
tract may increase intra-abdominal pressure and can be a 
predisposing factor for rectal prolapse [42]. In our study, 
the tumor derived from COLO320DM orthotopic injection 
initiated intussusception in young mice, which then 
resulted in rectal prolapse because of obstruction of the 
bowel and abdominal pressure. In accordance, several case 
studies reported rectal prolapse when adenocarcinoma 
of the sigmoid colon was present [44–46]. Patients with 
rectal prolapse showed a 4.2-fold relative risk for CRC 
in comparison with a control group [3]. In line with this 
data, McNicol et al. report that the association of rectal 
prolapse and rectal adenocarcinoma is not that rare. In one 
year two cases of complete rectal prolapse resulted in the 
diagnosis of primary sigmoid or rectal adenoacarcinoma 
[47]. Therefore, tumor masses may be associated with 
the development of intussusception. H&E staining of 
orthotopic COLO320DM tumors demonstrated a tumor 
mass with pushing borders, but without any invasive 
characteristics. Our data suggests that bioluminescent 
signal of the first three weeks post-inoculation may predict 
prolapse in the six weeks following orthotopic inoculation 
with COLO320DM in young mice. Bioluminescent signal 
corresponds with the number of cancer cells, thus a larger 
tumor in the beginning was associated with rectal prolapse 
later on.
COLO320DM cells may uniquely react to a young 
environment. To simulate an aging environment we 
induced replicative senescence in CAFs and investigated 
the functional impact of its secretome on COLO320DM 
cell growth. Supplementary Figure S2 shows young 
and replicative-aged CAFs differentially characterized 
by morphology, β-galactosidase activity and increased 
γ-H2AX and p21cip1 staining (Supplementary Figure 
S2A-S2C). The secretome of replicative aged CAFs 
reduced cancer cell growth compared to the secretome 
of young CAFs (p=0.021; Supplementary Figure S2D). 
CAFs play a critical role in CRC progression, particularly 
by the secretion of several factors [16]. The secreted 
factors from CAFs may be age-dependent as was shown 
by Kaur et al. for dermal fibroblasts [48]. Aged fibroblasts 
secreted more sFRP, an inhibitor of β-catenin, leading 
to decreased melanoma cell proliferation and increased 
invasion [48]. However, the reduction of cancer cell 
Table 2: Overview of the literature reporting intra-caecal injection of single cell suspensions and comparison with 
our results
Author Mouse strain Gender Age Cell line Cell number Take rate Prolapse
Our results Swiss Nu/Nu female 6 weeks COLO320DM 1x106 62.5% Yes
> 12 weeks COLO320DM 1x106 62.5% No
6 weeks HT29 1x106 62.5% No
Céspedes  
et al. [9]
Swiss Nu/Nu male 4 weeks HCT-116 2x106 75% No
SW-620 2x106 75% No
DLD-1 2x106 88% No
Hackl  
et al. [6]
CB17SCID female 6 weeks HT29 5x105 87.5 – 100% No
HCT-116 5x105 87.5 – 100% No
Van Hoorde 
et al. [10]
Swiss Nu/Nu male 6 weeks HCT-8/E11 ? > 50 % No
Sasaki  
et al. [7]
Athymic nude 
(NCl-nu)
male 8-12 weeks SW-620 5x105 100% No
Kitadai  
et al. [11]
Athymic  
Ncr-nu/nu
male 8-12 weeks KM12SM 2x106 100% No
Rebhun  
et al. [12]
Athymic nude 
(Ncl-nu)
male 8-12 weeks HT29 1x106 100% No
Yokoi  
et al. [8]
Athymic nude 
(Ncl-nu)
male 8-12 weeks HT29 1x106 100% No
Morikawa 
et al. [13]
Athymic 
BALB/c nude
male 8 weeks KM12 1x106 100% No
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growth in vitro was not observed in adult mice in 
comparison with young mice bearing a COLO320DM 
tumor, as shown by the bioluminescent signal (Figure 
3B). Furthermore, no difference in invasion was observed 
as H&E staining revealed a non-invasive phenotype with 
pushing borders for both tumors from young and adult 
mice (Supplementary Figure S3). Therefore CAFs and 
their age may have an influence on CRC cells, but it is not 
likely to be the only factor responsible for rectal prolapse.
In conclusion, the phenotype of prolapse may be 
due to a combination of the anatomy of young mice, the 
non-invasive type of tumor, the serotonin secreted by the 
cancer cells and the young environment.
MATERIALS AND METHODS
Cell lines and cell culture
The human CRC cell line COLO320DM was 
isolated from a carcinoma of the sigmoid colon from a 
55-year-old Caucasian female by Quinn et al. [14]. Double 
minutes (DM) were initially present in nearly all of the 
metaphases [14]. Cells grow both attached to the culture 
flask and in suspension. COLO320DM was cultured 
in glutamax enriched Roswell Park Memorial Institute 
medium (RPMI) 1640 supplemented with 10% fetal 
bovine serum (FBS) and antibiotics (100 U/ml penicillin, 
100 μg/ml streptomycin). Cultures were maintained at 
37°C in 5% CO
2
 in air. COLO320DM was chemically 
transfected with a firefly luciferase vector (pGL4.50 [luc2/
CMV/Hygro] vector; Promega, Leiden, The Netherlands) 
by using TurboFect Transfection Reagent (Thermo 
Scientific, Erembodegem – Aalst, Belgium) following 
the manufacturer’s recommendations. The human CRC 
cell line HT29 transfected with a firefly luciferase vector 
was kindly provided by Dr. Hackl (University of Toronto)
[6]. HT29, HCT8/E11 and telomerase-immortalized 
human colon CAFs were cultured in Dulbecco’s minimal 
essential medium (DMEM) supplemented with 10% FBS, 
100 U/ml penicillin, 100 μg/ml streptomycin and 2 μg/ml 
fungizone (Life Technologies, Ghent, Belgium). Isolation 
and characterization of the CAFs was previously described 
[49]. Cultures were maintained at 37°C in 10% CO
2
 in 
air. All cultures were regularly tested for Mycoplasma. 
Phase/contrast microscope Leica DMI 3000B connected 
with Leica DFC 340FX and LAS4.1 software was used 
to make phase/contrast pictures. Authentication of both 
COLO320DM and HT29 was verified by short tandem 
repeat DNA profiling.
Cell lysates and western blot
COLO320DM, luciferase transfected COLO320DM, 
HCT8/E11, CAFs and BLM transfected to overexpress 
P-cadherin were harvested in Laemmli lysis buffer (0.125 
M Tris-HCl, 10% glycerol, 2.3% sodium dodecyl sulfate 
(SDS), pH 6.8). Cell lysates were suspended in reducing 
sample buffer (1 M Tris-HCl, 30% glycerol, 6% SDS, 3% 
β-mercaptoethanol, 0.005% bromophenol blue, pH 6.8) 
and boiled for 5 minutes at 95°C. Twenty μg proteins of 
each cell line were exposed to SDS-PAGE gels, transferred 
to nitrocellulose membranes (Bio-Rad, Hercules, CA, 
USA), blocked in 5% non-fat milk in phosphate-buffered 
saline (PBS) with 0.5% Tween-20 (Sigma-Aldrich, 
Belgium) and immunostained.
The following antibodies were used: mouse anti-
CD29 (clone 18/CD29), mouse anti-P-cadherin (Clone 
56/P-cadherin) (BD Biosciences), mouse monoclonal anti-
Pan cadherin, monoclonal anti-β-catenin (Clone 15B8), 
mouse monoclonal anti-vimentin, mouse monoclonal anti-
cytokeratin, pan antibody (Sigma-Aldrich, Belgium) and 
mouse monoclonal anti-human E-cadherin (clone HECD-
1; Takara, Japan). The primary antibody against tubulin 
used for loading control was the mouse monoclonal anti-
α-tubulin (clone B-5-1-2, Sigma-Aldrich, Belgium).
Collagen invasion assay
Collagen invasion assay was performed as described 
previously [50]. Briefly, 1x105 COLO320DM cells were 
seeded on 0.1% type I collagen gels (Santa Cruz, Santa 
Cruz, California, USA) in RPMI 1640 with 0.5% FBS. As 
a positive control, HCT8/E11 cells were seeded on 0.1% 
type I collagen gels in normal cell culture conditions. 
Morphology and collagen invasion were analyzed after 24h.
xCELLigence Real-Time Cell Analysis (RTCA): 
migration
Real-time monitoring of cell migration was 
performed by using xCELLigence DP Real Time Cell 
Analyzer (RTCA, Westburg, Leusden, The Netherlands) 
according to the manufacturer’s guidelines and as 
described by Limame et al [51]. Modified 16-well plates 
(Westburg) were used with upper and lower chambers 
separated by a microporous membrane containing 8 μm-
pores. Microelectrodes are attached to the bottom of the 
membrane for impedance-based detection of migrated 
cells. In the lower chambers 160 μl medium with 10% 
FBS was added. In the upper well 50 μl of serum-free 
medium was added, followed by one hour incubation at 
37°C and 5% CO
2
. Subsequently the background signal 
was measured. 160000 COLO320DM or HCT8/E11 cells 
were seeded per upper chamber in 100 μl serum-free 
medium. Each condition was performed in duplicate and 
impedance was measured each fifteen minutes for 24h. All 
data have been recorded by the supplied RTCA software 
2.0. Migration was expressed as the cell index, i.e. the 
change in electrical impedance at each time point.
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Animals
Female immune-deficient Swiss nu/nu mice 
(Charles River Laboratories, l’Arbresle Cedex, France) 
were used. Animal studies were approved by the Animal 
Ethics Committee of Ghent University, Belgium.
SC implantation of CRC cells
Six-weeks-old, which is considered as young, mice 
were inoculated SC with 1x106 luciferase transfected 
COLO320DM cells alone (n=5) or in combination with 
2.5x106 non-irradiated (n=5) or irradiated (n=5) CAFs, 
in 50 μl PBS (Figure 1B). In vitro cultures of CAFs 
were exposed to 1.8 Gy daily for two weeks (five days/
week) before inoculation, but no difference in results 
was obtained in mice inoculated with irradiated or non-
irradiated CAFs.
Orthotopic (intra-caecal) injection of CRC cells
Surgical procedures were performed under general 
anesthesia (IsoFlo, Abbott, Belgium) and analgesia 
(Ketoprofen, 5 mg/kg). A small midline laparotomy was 
executed and the caecum was located in the abdominal 
cavity. The caecum was then gently exteriorized and 
placed on a microscope slide connected to two bearers 
serving as a small table to stabilize the caecum and avoid 
pressure on the animal. The caecum was flattened with 
a forceps and by using a 300 μL insulin syringe with a 
30G needle, a volume of 10 μL cells in serum-free DMEM 
was injected into the caecal wall under 2.5x magnification 
(OPMI 6, Zeiss, Germany). Successful injection was 
determined as the appearance of a small bleb without 
any leakage (Figure 1C). The caecum was then carefully 
returned to the abdominal cavity and the laparotomy was 
closed in two layers by sutures of PDS 6/0.
In a first group, adult mice, more than 12 weeks of 
age, were intra-caecally injected with 1x106 luciferase 
transfected COLO320DM cells in combination with 2.5x106 
CAFs (n=8). Furthermore, six-weeks-old, young, mice were 
intra-caecally injected with 1x106 luciferase transfected 
COLO320DM cells in combination with 2.5x106 CAFs 
whether irradiated (n=8) or not (n=8). Exposure of CAFs 
to daily doses of 1.8 Gy for two weeks (five days/week) did 
not influence the outcome in mice (data not shown). In a 
last group, six-weeks-old, young, mice were intra-caecally 
injected with 1x106 luciferase transfected HT29 cells in 
combination with 2.5x106 CAFs (n=8).
In vivo monitoring
Tumor development was weekly assessed by 
bioluminescence imaging until six weeks after inoculation. 
Mice were intraperitoneally injected with 150 mg/kg body 
weight Luciferin (Caliper Life Sciences, Hopkinton, MA) 
ten minutes before bioluminescence imaging, which was 
carried out by using an IVIS Lumina II (Caliper Life 
Sciences).
Necropsy and histology
Animals were sacrificed when signs of disease 
were observed. Necropsy was performed and organs were 
sampled for histological examination. Organs were fixed 
with buffered formalin for 24 hours and subsequently 
paraffin-embedded. Standard H&E staining was applied to 
5-μm thick sections. Sections were analyzed with a Leica 
DM750 light microscope. Pictures were taken with Leica 
MC170HD camera connected to the microscope using 
LAS4.3 software.
Immunohistochemistry
Standard immunohistochemistry was applied to 
5-μm thick sections using specific antibodies against CD56 
(DAKO, Heverlee, Belgium; clone 123C3, 1/100), against 
chromogranin (Menarini, Zaventem, Belgium; clone 
5H7, 1/200) and against synaptophysin (Menarini; clone 
27G12, 1/100). Immunohistochemistry was performed on 
the BOND-MAX (Leica, Wetzlar, Germany). Briefly, the 
immunohistochemical expression was visualized using 
the Bond Polymer Refine Detection kit (Menarini; kit 
DS9800) for CD56 and chromogranin and using the Bond 
Intense R Detection (Menarini) for synaptophysin. The 
sections were counterstained with haematoxylin.
Statistical analysis
Statistical analysis was performed with IBM 
SPSS statistics 21. The end point to apply statistics was 
set on six weeks post-inoculation. Survival curves were 
evaluated using Kaplan-Meier survival and log rank test. 
Comparison of prolapse in several groups was carried out 
by Fischer exact test. In vivo bioluminescent signals were 
analyzed by linear regression mixed models after log10 
transformation. Bioluminescent signals for one time point 
were analyzed by Mann-Whitney U test.
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